101 evolution "https:" "https:" "https:" "CMU Portugal Program FCT" positions at KU LEUVEN
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
. Where to apply Website https://www.kuleuven.be/personeel/jobsite/jobs/60629842?hl=en Requirements Research FieldJuridical sciencesEducation LevelMaster Degree or equivalent LanguagesDUTCHLevelExcellent
-
: inge.vanhulle@kuleuven.be or Prof. dr. Wouter Druwé, mail: wouter.druwe@kuleuven.be .In case of problems with the online application, please contact solliciteren@kuleuven.be . Where to apply Website https
-
or resist specific policies. The project combines theory development with qualitative fieldwork in the Belgian and French contexts. The project requires a PhD candidate who combines theoretical curiosity with
-
for their application in the development of lightweight, insulating gypsum plaster. This position lies at the intersection of green chemistry, carbon capture and utilization, building materials, and sustainable
-
Research Council (ERC) Starting Grant https://www.kuleuven.be/english/research/EU/p/he/p1/erc/IonFracMem ) aims to address this challenge by developing novel membranes that combine fast throughput with
-
additional biomarker candidates•Contribute to the development of biomarker panels with diagnostic and/or prognostic potential The ideal candidate will have:•A Master’s degree in biomedical sciences
-
River Delta with its early 'megapolises' (e.g. Hangzhou, Suzhou, Yangzhou). You will trace the development of a range of techniques for building in marshy urban conditions, particularly in the Song and
-
, hence requiring robustness and meeting all relevant industry standards. PhD research project The objective of this PhD is to contribute to the investigation, development, and valorization of self-learning
-
. This PhD project aims to investigate wind–planet interactions in systems with cool evolved stars, focusing on how stellar outflows shape planetary atmospheric structure, chemistry, and long-term evolution
-
fluid. Based on this, an innovative biomarker platform will be rolled out that aims to increase the success rate of early-phase clinical studies and ultimately accelerate the development of an effective